Phase I clinical trial of the chimeric anti-mesothelin monoclonal antibody MORAb-009 in patients with mesothelin-expressing cancers.

Source:http://linkedlifedata.com/resource/pubmed/id/21037025

Clin. Cancer Res. 2010 Dec 15 16 24 6132-8

Download in:

View as

General Info

PMID
21037025